The inflammatory cytokine, GM-CSF, alters the developmental outcome of murine dendritic cells

European Journal of Immunology

Volumn 42, Issue 11, 2012, Pages 2889-2900

  Zhan, Yifan ^a,b   Vega Ramos, Javier ^a,b   Carrington, Emma M ^a,b   Villadangos, Jose A ^a,b   Lew, Andrew M ^a,b   Xu, Yuekang ^a,b,c  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c Anhui Medical University ^*  (Switzerland)

Author keywords

Dendritic cells and differentiation; Flt3L; GM CSF

Indexed keywords

CYTOKINE; FMS LIKE TYROSINE KINASE 3 LIGAND PROTEIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD8+ T LYMPHOCYTE; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGENY; TRANSGENICS;

EID: 84866537688     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201242477     Document Type: Article

References (47)

1. Kondo, M., Wagers, A. J., Manz, M. G., Prohaska, S. S., Scherer, D. C., Beilhack, G. F., Shizuru, J. A. et al., Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annu. Rev. Immunol. 2003. 21: 759-806.
2. Shortman, K. and Liu, Y. J., Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2002. 2: 151-161.
3. Liu, Y. J., Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell 2001. 106: 259-262.
4. Xu, Y., Zhan, Y., Lew, A. M., Naik, S. H. and Kershaw, M. H., Differential development of murine dendritic cells by GM-CSF versus Flt3 ligand has implications for inflammation and trafficking. J. Immunol. 2007. 179: 7577-7584.
5. Shortman, K. and Naik, S. H., Steady-state and inflammatory dendritic-cell development. Nat. Rev. Immunol. 2007. 7: 19-30.
6. Vremec, D., Pooley, J., Hochrein, H., Wu, L. and Shortman, K., CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen. J. Immunol. 2000. 164: 2978-2986.
7. den Haan, J. M., Lehar, S. M. and Bevan, M. J., CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. J. Exp. Med. 2000. 192: 1685-1696.
8. Hochrein, H., Shortman, K., Vremec, D., Scott, B., Hertzog, P. and O'Keeffe, M., Differential production of IL-12, IFN-alpha, and IFN-gamma by mouse dendritic cell subsets. J. Immunol. 2001. 166: 5448-5455.
9. Serbina, N. V., Salazar-Mather, T. P., Biron, C. A., Kuziel, W. A. and Pamer, E. G., TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity 2003. 19: 59-70.
10. Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S., Muramatsu, S. et al., Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 1992. 176: 1693-1702.
11. Blom, B., Ho, S., Antonenko, S. and Liu, Y. J., Generation of interferon alpha-producing predendritic cell (Pre-DC)2 from human CD34(+) hematopoietic stem cells. J. Exp. Med. 2000. 192: 1785-1796.
12. Naik, S. H., Proietto, A. I., Wilson, N. S., Dakic, A., Schnorrer, P., Fuchsberger, M., Lahoud, M. H. et al., Cutting edge: generation of splenic CD8+ and CD8- dendritic cell equivalents in Fms-like tyrosine kinase 3 ligand bone marrow cultures. J. Immunol. 2005. 174: 6592-6597.
13. McKenna, H. J., Stocking, K. L., Miller, R. E., Brasel, K., De Smedt, T., Maraskovsky, E., Maliszewski, C. R. et al., Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells. Blood 2000. 95: 3489-3497.
14. Hamilton, J. A., GM-CSF in inflammation and autoimmunity. Trends Immunol. 2002. 23: 403-408.
15. Naik, S. H., Metcalf, D., van Nieuwenhuijze, A., Wicks, I., Wu, L., O'Keeffe, M. and Shortman, K., Intrasplenic steady-state dendritic cell precursors that are distinct from monocytes. Nat. Immunol. 2006. 7: 663-671.
16. Kingston, D., Schmid, M. A., Onai, N., Obata-Onai, A., Baumjohann, D. and Manz, M. G., The concerted action of GM-CSF and Flt3-ligand on in vivo dendritic cell homeostasis. Blood 2009. 114: 835-843.
17. Cheers, C., Haigh, A. M., Kelso, A., Metcalf, D., Stanley, E. R. and Young, A. M., Production of colony-stimulating factors (CSFs) during infection: separate determinations of macrophage-, granulocyte-, granulocyte-macrophage-, and multi-CSFs. Infect. Immun. 1988. 56: 247-251.
18. Bohannon, J. K., Cui, W. and Toliver-Kinsky, T., Endogenous Fms-like tyrosine kinase-3 ligand levels are not altered in mice after a severe burn and infection. BMC Immunol. 2009. 10: 47.
19. Gilliet, M., Boonstra, A., Paturel, C., Antonenko, S., Xu, X. L., Trinchieri, G., O'Garra, A. and Liu, Y. J., The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 2002. 195: 953-958.
20. Esashi, E., Wang, Y. H., Perng, O., Qin, X. F., Liu, Y. J. and Watowich, S. S., The signal transducer STAT5 inhibits plasmacytoid dendritic cell development by suppressing transcription factor IRF8. Immunity 2008. 28: 509-520.
21. Xu, Y., Schnorrer, P., Proietto, A., Kowalski, G., Febbraio, M. A., Acha-Orbea, H., Dickins, R. A. et al., IL-10 controls cystatin C synthesis and blood concentration in response to inflammation through regulation of IRF-8 expression. J. Immunol. 2011. 186: 3666-3673.
22. Naik, S. H., Sathe, P., Park, H. Y., Metcalf, D., Proietto, A. I., Dakic, A., Carotta, S. et al., Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo. Nat. Immunol. 2007. 8: 1217-1226.
23. Zhan, Y., Xu, Y., Seah, S., Brady, J. L., Carrington, E. M., Cheers, C., Croker, B. A. et al., Resident and monocyte-derived dendritic cells become dominant IL-12 producers under different conditions and signaling pathways. J. Immunol. 2010. 185: 2125-2133.
24. Nikolic, T., de Bruijn, M. F., Lutz, M. B. and Leenen, P. J., Developmental stages of myeloid dendritic cells in mouse bone marrow. Int. Immunol. 2003. 15: 515-524.
25. Laouar, Y., Welte, T., Fu, X. Y. and Flavell, R. A., STAT3 is required for Flt3L-dependent dendritic cell differentiation. Immunity 2003. 19: 903-912.
26. Hattersley, G., Dorey, E., Horton, M. A. and Chambers, T. J., Human macrophage colony-stimulating factor inhibits bone resorption by osteoclasts disaggregated from rat bone. J. Cell. Physiol. 1988. 137: 199-203.
27. Rieger, M. A., Hoppe, P. S., Smejkal, B. M., Eitelhuber, A. C. and Schroeder, T., Hematopoietic cytokines can instruct lineage choice. Science 2009. 325: 217-218.
28. Vremec, D., Lieschke, G. J., Dunn, A. R., Robb, L., Metcalf, D. and Shortman, K., The influence of granulocyte/macrophage colony-stimulating factor on dendritic cell levels in mouse lymphoid organs. Eur. J. Immunol. 1997. 27: 40-44.
29. Sathe, P., Pooley, J., Vremec, D., Mintern, J., Jin, J. O., Wu, L., Kwak, J. Y. et al., The acquisition of antigen cross-presentation function by newly formed dendritic cells. J. Immunol. 2011. 186: 5184-5192.
30. Zhan, Y., Carrington, E. M., van Nieuwenhuijze, A., Bedoui, S., Seah, S., Xu, Y., Wang, N. et al., GM-CSF increases cross-presentation and CD103 expression by mouse CD8 spleen dendritic cells. Eur. J. Immunol. 2011. 41: 2585-2595.
31. Kamath, A. T., Pooley, J., O'Keeffe, M. A., Vremec, D., Zhan, Y., Lew, A. M., D'Amico, A. et al., The development, maturation, and turnover rate of mouse spleen dendritic cell populations. J. Immunol. 2000. 165: 6762-6770.
32. Fuertes Marraco, S. A., Scott, C. L., Bouillet, P., Ives, A., Masina, S., Vremec, D., Jansen, E. S. et al., Type I interferon drives dendritic cell apoptosis via multiple BH3-only proteins following activation by PolyIC in vivo. PLoS One 2011. 6: e20189.
33. Metcalf, D., Shortman, K., Vremec, D., Mifsud, S. and Di Rago, L., Effects of excess GM-CSF levels on hematopoiesis and leukemia development in GM-CSF/max 41 double transgenic mice. Leukemia 1996. 10: 713-719.
34. Maraskovsky, E., Brasel, K., Teepe, M., Roux, E. R., Lyman, S. D., Shortman, K. and McKenna, H. J., Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J. Exp. Med. 1996. 184: 1953-1962.
35. Hanada, K., Tsunoda, R. and Hamada, H., GM-CSF-induced in vivo expansion of splenic dendritic cells and their strong costimulation activity. J. Leukoc. Biol. 1996. 60: 181-190.
36. Bronte, V., Chappell, D. B., Apolloni, E., Cabrelle, A., Wang, M., Hwu, P. and Restifo, N. P., Unopposed production of granulocyte-macrophage colony-stimulating factor by tumors inhibits CD8+ T cell responses by dysregulating antigen-presenting cell maturation. J. Immunol. 1999. 162: 5728-5737.
37. Daro, E., Pulendran, B., Brasel, K., Teepe, M., Pettit, D., Lynch, D. H., Vremec, D. et al., Polyethylene glycol-modified GM-CSF expands CD11b(high)CD11c(high) but notCD11b(low)CD11c(high) murine dendritic cells in vivo: a comparative analysis with Flt3 ligand. J. Immunol. 2000. 165: 49-58.
38. Pulendran, B., Lingappa, J., Kennedy, M. K., Smith, J., Teepe, M., Rudensky, A., Maliszewski, C. R. et al., Developmental pathways of dendritic cells in vivo: distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand-treated mice. J. Immunol. 1997. 159: 2222-2231.
39. Gillessen, S., Naumov, Y. N., Nieuwenhuis, E. E., Exley, M. A., Lee, F. S., Mach, N., Luster, A. D. et al., CD1d-restricted T cells regulate dendritic cell function and antitumor immunity in a granulocyte-macrophage colony-stimulating factor-dependent fashion. Proc. Natl. Acad. Sci. USA 2003. 100: 8874-8879.
40. Mach, N., Gillessen, S., Wilson, S. B., Sheehan, C., Mihm, M. and Dranoff, G., Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand. Cancer Res. 2000. 60: 3239-3246.
41. Tamura, T., Kimura, K., Yuda, M. and Yui, K., Prevention of experimental cerebral malaria by Flt3 ligand during infection with Plasmodium berghei ANKA. Infect. Immun. 2011. 79: 3947-3956.
42. Grau, G. E., Kindler, V., Piguet, P. F., Lambert, P. H. and Vassalli, P., Prevention of experimental cerebral malaria by anticytokine antibodies. Interleukin 3 and granulocyte macrophage colony-stimulating factor are intermediates in increased tumor necrosis factor production and macrophage accumulation. J. Exp. Med. 1988. 168: 1499-1504.
43. Zhan, Y., Lieschke, G. J., Grail, D., Dunn, A. R. and Cheers, C., Essential roles for granulocyte-macrophage colony-stimulating factor (GM-CSF) and G-CSF in the sustained hematopoietic response of Listeria monocytogenes-infected mice. Blood 1998. 91: 863-869.
44. Scott, C. L., Robb, L., Papaevangeliou, B., Mansfield, R., Nicola, N. A. and Begley, C. G., Reassessment of interactions between hematopoietic receptors using common beta-chain and interleukin-3-specific receptor beta-chain-null cells: no evidence of functional interactions with receptors for erythropoietin, granulocyte colony-stimulating factor, or stem cell factor. Blood 2000. 96: 1588-1590.
45. Lang, R. A., Metcalf, D., Cuthbertson, R. A., Lyons, I., Stanley, E., Kelso, A., Kannourakis, G. et al., Transgenic mice expressing a hemopoietic growth factor gene (GM-CSF) develop accumulations of macrophages, blindness, and a fatal syndrome of tissue damage. Cell 1987. 51: 675-686.
46. Xu, Y., Darcy, P. K. and Kershaw, M. H., Tumor-specific dendritic cells generated by genetic redirection of Toll-like receptor signaling against the tumor-associated antigen, erbB2. Cancer Gene Ther. 2007. 14: 773-780.
47. El-Sukkari, D., Wilson, N. S., Hakansson, K., Steptoe, R. J., Grubb, A., Shortman, K. and Villadangos, J. A., The protease inhibitor cystatin C is differentially expressed among dendritic cell populations, but does not control antigen presentation. J. Immunol. 2003. 171: 5003-5011.